AMRN · Amarin Corp ADR
United States · RS rating 33 · As of 2026-11-03
| Price | 12.05 USD |
|---|---|
| 1-day change | -0.7% |
| RS rating (overall / 1M / 3M / 12M) | 33 / 55 / 36 / 33 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 26 / 8 / 48 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +100.0% |
| Sales growth Q/Q | -0.9% |
| Distance from 52-week high | +29.0% |
| Market cap (USD) | $306.0M |